Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.
High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...
Thousands of NHS patients to benefit from ‘take at home’ multiple sclerosis tablet in European first
Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out ...
Merck KGaA’s Mavenclad (cladribine) tablets have been recommended by the National Institute for Health and Care Excellence ...
The list price of Mavenclad is around £2,050 per 10mg tablet, although, Merck is providing it to the NHS in England at a ...
The Scottish Medicines Consortium is reviewing cladribine for broader use in relapsing forms of the condition.
The move will also “significantly free up clinical time” by reducing the need for hospital appointments, officials said. | ITV National News ...
The medication, which will be rolled out to patients with relapsing-remitting MS, is thought to be the first in Europe to be ...
Leg-spinner Yuzvendra Chahal's maiden six-wicket for India as the hosts beat England by 75 runs in the third and final Twenty20 International ...
The Merck KGaA collaborated with actress and patient advocate Selma Blair for the I’m Ready campaign. When EMD Serono embarked on a campaign to empower patients living with relapsing multiple ...
A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback